stockrow
Friday 6 November 2026
Export PHG’s income statement to Excel — free account
Koninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.
- Revenue
- +0.55%
- EPS
- −85.0%
- Free cash flow
- +154.2%
- Total debt
- −4.96%
Quarter to September 2026, against a year earlier
30.29
0.22
−0.72%
Follow PHG
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
— | 7 | — | — |
+8 more TTM periods Free account |
| 8.54% | 10.20% | 8.63% | 8.02% | ||
| 3.49% | 4.21% | 3.67% | 3.25% | ||
ROIC |
6.15% | 6.69% | 5.91% | 5.91% | |
Return on Tangible Assets |
19.89% | 27.07% | 20.90% | 19.29% | |
Average Days of Receivables |
73.73 | 74.19 | 69.14 | 73.47 | |
Free Cash Flow per Share |
2.17 | 1.94 | 1.85 | 0.61 | |
Free Cash Flow |
2,116.65 | 1,849.65 | 1,763.60 | 580.41 | |
Capital Expenditures |
(740.65) | (751.93) | (765.35) | (745.59) | |
| Other line items | |||||
Cash ROIC |
8.60% | 8.10% | 7.18% | 2.47% | |
Accounts Receivable Turnover |
5.12 | 5.17 | 5.42 | 4.86 | |
Accounts Payable Turnover |
4.95 | 3.70 | 5.26 | 5.30 | |
Inventory Turnover |
2.86 | 3.00 | 3.13 | 3.10 | |
Average Days of Payables |
81.30 | 79.35 | 75.92 | 71.95 | |
Days of Inventory on Hand |
129.57 | 122.68 | 118.66 | 107.16 | |
Tax Rate |
(0.28) | (0.25) | (0.24) | (0.24) | |
Research and Development Expense of Revenue |
9.69% | 9.77% | 9.31% | 9.53% | |
Selling, General and Administrative Expense of Revenue |
27.50% | 27.66% | 27.87% | 27.87% | |
Share Based Compensation of Revenue |
0.84% | 0.80% | 0.71% | 0.79% | |
Interest Coverage |
4.19 | 4.70 | 4.30 | 4.12 | |
Operating CF/Net income |
2.60 | 2.03 | 2.28 | 1.31 | |
Depreciation/Fixed assets |
0.52 | 0.56 | 0.51 | 0.51 | |
Capex/Depreciation |
(0.56) | (0.53) | (0.59) | (0.59) | |
Revenue per Share |
21.08 | 21.53 | 21.47 | 21.28 | |
Operating CF per Share |
2.92 | 2.72 | 2.66 | 1.40 | |
Capex per Share |
(0.76) | (0.79) | (0.80) | (0.79) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.04 |
Columns are period end dates · fundamentals updated 5 Nov 2026